0001179110-16-028541.txt : 20160810 0001179110-16-028541.hdr.sgml : 20160810 20160810202147 ACCESSION NUMBER: 0001179110-16-028541 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160726 FILED AS OF DATE: 20160810 DATE AS OF CHANGE: 20160810 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Onconova Therapeutics, Inc. CENTRAL INDEX KEY: 0001130598 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 375 PHEASANT RUN CITY: NEWTOWN STATE: PA ZIP: 18940 BUSINESS PHONE: 267-759-3681 MAIL ADDRESS: STREET 1: 375 PHEASANT RUN CITY: NEWTOWN STATE: PA ZIP: 18940 FORMER COMPANY: FORMER CONFORMED NAME: ONCONOVA THERAPEUTICS, INC. DATE OF NAME CHANGE: 20090526 FORMER COMPANY: FORMER CONFORMED NAME: ONCONOVA THERAPEUTICS INC DATE OF NAME CHANGE: 20001226 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Reddy E Premkumar CENTRAL INDEX KEY: 0001580071 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36020 FILM NUMBER: 161822738 MAIL ADDRESS: STREET 1: 375 PHEASANT RUN CITY: NEWTOWN STATE: PA ZIP: 18940 4 1 edgar.xml FORM 4 - X0306 4 2016-07-26 0 0001130598 Onconova Therapeutics, Inc. ONTX 0001580071 Reddy E Premkumar C/O ONCONOVA THERAPEUTICS, INC. 375 PHEASANT RUN NEWTOWN PA 18940 1 0 0 0 Common Stock 2016-07-29 4 X 0 133000 4.10 A 266784 D Subscription Rights (right to receive) 4.10 2016-07-26 4 X 0 133000 0 D 2016-07-08 2016-07-26 See footnote 133000 0 D Warants (right to buy) 4.92 2016-07-29 4 X 0 99750 A 2016-07-29 2021-07-27 Common Stock 99750 99750 D The common stock and the warrants reported on this Form 4 were acquired pursuant to the exercise of subscription rights previously distributed by the Issuer to all holders of the Issuer's common stock. Each holder received 1.5 subscription rights per share of stock owned, and each right allowed the recipient to purchase one unit, consisting of one share of common stock and 0.75 of a warrant to purchase one share of common stock. The subscription price per unit was $4.10. Holders of the subscription rights, including the Reporting Person, also had an overallotment privilege to subscribe for additional units not purchased by other holders, subject to allocation. The allocation of the overallotment privilege to persons who hold their securities through a broker was completed on August 1, 2016. Each warrant entitles the holder to purchase one share of the Company's common stock at an exercise price of $4.92 from the date of issuance through July 27, 2021. /s/ Ramesh Kumar as attorney-in-fact 2016-08-10